Navigation Links
Akela Pharma reports results for third quarter of fiscal 2007
Date:11/9/2007

http://www.akelapharma.com Toronto Stock Exchange Symbol: AKL

MONTREAL, Nov. 9 /PRNewswire-FirstCall/ - Akela Pharma Inc. (TSX: AKL), a drug development company focused on developing therapies for the inhalation and pain markets, today announced its financial results under Canadian generally accepted accounting principles for the three and six month period ended September 30, 2007 and 2006.

Akela's consolidated net loss for the third quarter of 2007 was $8.6 million compared to net income of $12.0 million for the segmented Pharma results for the same 2006 period. The results of operations for the three and nine months ended September 30, 2006 include a gain on disposal of our interest in LAB Research totaling $18.6 million.

"The Third quarter fiscal 2007 was marked by important clinical achievements. We first announced positive results from our GHRH Phase II trial demonstrating a marked stimulation of growth hormone and IGF-1 production followed by positive results for our lead product Fentanyl TAIFUN(R) for the Phase IIb extension arm trial demonstrating efficacy resulting in faster and superior pain relief. Having once again delivered significantly positive clinical milestones we now continue to confidently advance our product development programs." said Dr Halvor Jaeger, Chief Executive Officer of Akela Pharma Inc.

Other Third Quarter Financial Highlights

- Total consolidated revenues for the third quarter of 2007 were

$3.1 million, including $1.1 million in co-development fees and

$1.9 million of contract services. Total consolidated revenues for the

first 9 months of 2007 were $7.9 million, including $1.6 million in

co-development fees and $5.7 million of contract services.

- Consolidated net loss for the third quarter of 2007 was $8.6 million or

($0.73) per share. Consolidated net loss year-to-date is $23.8 million<
'/>"/>

SOURCE Akela Pharma Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
2. Akela Pharma Inc. Completes Share Consolidation
3. AKELA Pharma Inc. announces U.S. public offering and proposed listing
4. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
5. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
9. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... The world wound care market is ... and reach USD 18.3 billion by 2019, posting a ... of such growth include governments’ contribution to the development ... and surging ageing population. However, the growth could be ... Region-wise, North America leads the global wound care market, ...
(Date:8/21/2014)... 2014 Revista, a one-stop source ... industry-focused data, is “on a roll.” Today, the ... on the Southeast, Mid-Atlantic and Midwest areas of ... first widely available, comprehensive medical property database tracking ... searchable properties, including existing and recently added, is ...
(Date:8/21/2014)... two types of polio vaccines seems to provide stronger ... eradicate polio, a new study shows. The research ... the Salk inactivated poliovirus vaccine (IPV) to those who ... vaccine (OPV) appeared to improve their immunity to the ... the Aug. 22 issue of the journal Science ...
(Date:8/21/2014)... The American College of Chest Physicians (CHEST) announces ... Ill and Injured During Pandemics and Disasters: CHEST ... of the journal CHEST while the ... Ebola virus. The consensus statement aims to guide ... research in crises. The statement was developed by ...
(Date:8/21/2014)... 2014Popular fiction that normalizes and glamorizes violence against women, ... associated with a greater risk of potentially harmful health ... study are presented in the article " Fiction or ... Adolescent and Young Adult Females ," published in ... Mary Ann Liebert, Inc., publishers . The article ...
Breaking Medicine News(10 mins):Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 2Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 3Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 2Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 3Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 4Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 5Health News:Two Polio Vaccines May Give Greater Protection Against Crippling Disease 2Health News:CHEST releases new expert guidance in care of the critically ill and injured 2Health News:Women's health and Fifty Shades: Increased risks for young adult readers? 2
... breakfast and lunch lose less weight compared to those who ... by researchers at Fred Hutchinson Cancer Research Center., The results ... a member of the Hutchinson Center,s Public Health Sciences Division ... the December issue of the Journal of the American ...
... researchers at Tel Aviv University have discovered that the two ... that movement and their survival. Fungal spores can ... travel. And while this allows them to travel further than ... TAU,s Raymond and Beverly Sackler School of Physics and Astronomy, ...
... 28 (HealthDay News) -- ,Heart function improved in obese people ... a small new study says. Researchers measured body-mass index ... fat in 15 obese people (seven men and eight women) ... started consuming a 500-calorie-per-day diet. Pericardial fat collects around ...
... a person with mild cognitive impairment is agitated or restless, ... well. According to research conducted at Virginia Tech, the more ... their loved one, the more they find themselves unable to ... This heightens the effect of elevated stress levels on their ...
... Foundation received two government grants to study the ... the rehabilitation and reintegration of people with spinal ... to Denise Fyffe, PhD, a research scientist in ... Fyffe, a clinical psychologist, is an expert in ...
... , SUNDAY, Nov. 27 (HealthDay News) -- Socializing ... people find it difficult. If you suffer anxiety or ... from Martin Antony, a psychology professor at Ryerson University in ... make eye contact. Be approachable and open to conversation. Join ...
Cached Medicine News:Health News:Mid-morning snacking may sabotage weight-loss efforts 2Health News:Mid-morning snacking may sabotage weight-loss efforts 3Health News:Fungi: Another tool in bacteria's belt? 2Health News:Low-Cal Diet Cuts Fat Around Heart in Obese People: Study 2Health News:Caregivers at risk for health problems 2Health News:Kessler Foundation receives grants to study health disparities in people with disabilities 2Health News:Surviving Holiday Parties When You Have Social Anxiety 2
(Date:8/21/2014)... , Aug. 21, 2014 Professional Compounding ... paediatric medicine by awarding the three best scientific ... initiative (EuPFI) conference . The Formulating Better ... 18 in Athens, Greece , ... students and professionals, from which three winners will ...
(Date:8/21/2014)... 2014 Asterias Biotherapeutics, Inc. (OTCBB: ASTY), a ... medicine, announced today the appointments of Andrew ("Andy") Arno ... Board of Directors. With these additions, the Asterias Board ... are independent. Andy Arno , 55, ... companies. He is currently Managing Director of Emerging Growth ...
(Date:8/20/2014)... LUTHERVILLE, Md. , Aug. 20, 2014 /PRNewswire/ ... (NADDI) today lauded the latest results achieved by ... system, known as the National Precursor Log Exchange ... law enforcement officials track down meth offenders and ... technology in Kansas blocked ...
Breaking Medicine Technology:Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... Bulb Direct has been ... Internet since 1996, and we ... 100% satisfaction guarantee. Check out ... and see our discount light ...
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... Bulb Direct has been ... Internet since 1996, and we ... 100% satisfaction guarantee. Check out ... and see our discount light ...
Medicine Products: